Save Stocks
Viewing
Filtered By
Ordered By
3 Biotech Stocks to Buy in February
2/2/2015 10:01:03 AM - Motley Fool


BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
1/22/2015 6:00:00 PM - Zacks.com


BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
1/22/2015 6:00:00 AM - Investopedia


BioMarin Prices Offering Of 8.5 Mln Shares At $93.25 Per Share
1/22/2015 1:16:00 AM - RTT News


3 Warning Signs You've Invested in a Dangerous Biotech Stock
1/17/2015 11:59:03 AM - Motley Fool


Health Care Sector Update for 01/15/2015: NVGN,BMRN,RNA,TNXP
1/15/2015 3:41:54 PM - MT Newswires


Health Care Sector Update for 01/15/2015: FLMN, FMS, BMRN, TNXP, RNA
1/15/2015 1:46:43 PM - MT Newswires


Update: BioMarin To Acquire Prosensa Holding N.V.
1/15/2015 8:27:00 AM - Seeking Alpha


BioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog
1/14/2015 5:10:00 PM - Zacks.com


BioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog
1/14/2015 5:10:00 AM - Investopedia


Why Sarepta Therapeutics Inc. Stock Tumbled 15% in December
1/9/2015 7:04:01 AM - Motley Fool


Cramer's Mad Money - Best Biotechs Of 2014 (1/6/15)
1/7/2015 5:38:00 AM - Seeking Alpha


Merger Arbitrage Mondays - January 5, 2015
1/5/2015 6:34:00 AM - Seeking Alpha


BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog
12/30/2014 5:10:00 PM - Zacks.com


BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog
12/30/2014 5:10:00 AM - Investopedia


Health Care Sector Update for 12/26/2014: BMRN,RNA,TPI,RHHBY
12/26/2014 4:01:57 PM - MT Newswires


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 PM - Zacks.com


BioMarin: Expiration Of Waiting Period Under HSR Act For Prosena Acquisition
12/24/2014 1:52:00 PM - RTT News


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 AM - Investopedia


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 PM - Zacks.com


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 AM - Investopedia


BIOD To Report Data Next Month, HALO Shines On Deal News, TTPH Gets Ignited
12/17/2014 11:26:00 PM - RTT News


3 Traits of the Best Healthcare Stocks in 2014
12/15/2014 7:20:02 AM - Motley Fool


Merger Opportunity: BioMarin To Adquire Prosensa
12/3/2014 7:57:00 AM - Seeking Alpha


Merger Arbitrage Mondays - December 1, 2014
12/1/2014 10:46:00 AM - Seeking Alpha